Photochemotherapy inhibits angiogenesis and induces apoptosis of endothelial cells in vitro

Photodermatology Photoimmunology and Photomedicine

Volumn 20, Issue 4, 2004, Pages 191-199

  Deng, Hui ^a   Yan, Chun Lin ^a   Hu, Yue ^a   Xu, Yu ^a   Liao, Kang Huang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Apoptosis; Endothelial cell; Photochemotherapy

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; METHOXSALEN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROVASCULARIZATION; NORMAL HUMAN; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PUVA; ULTRAVIOLET A RADIATION;

ANALYSIS OF VARIANCE; APOPTOSIS; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PUVA THERAPY;

EID: 4043181241     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2004.00099.x     Document Type: Article

References (42)

1. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389-395.
2. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-257.
3. Weinstein GD, McCullough JL, Ross PA. Cell kinetic basis for pathophysiology of psoriasis. J Invest Dermatol 1985; 85: 579-583.
4. Mordovtsev VN, Albanova VI. Morphology of skin microvasculature in psoriasis. Am J Dermatopathol 1989; 11: 33-42.
5. Baker BS, Fry L. The immunology of psoriasis. Br J Dermatol 1992; 126: 1-9.
6. Ragaz A, Ackerman AB. Evolution maturation, and regression of lesions of psoriasis. Am J Dermatopathol 1979; 1: 199-214.
7. Hull SM, Goodfield M, Wood EJ, Cunliffe WJ. Active and inactive edges of psoriasis plaques: identification by tracing and investigation by laser-Doppler flowmetry and im-munocyto-chemical techniques. J Invest Dermatol 1989; 92: 782-785.
8. Braverman IM, Sibley J. Role of the microcirculation in the treatment and pathogenesis of psoriasis. J Invest Dermatol 1982; 78: 12-17.
9. + perivascular dendritic cells. J Invest Dermatol 1991; 96: 333-340.
10. Malhotra R, Stenn KS, Fernandez LA, Braverman IM. Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis. Lab Invest 1989; 61: 162-165.
11. Yaguchi H, Tsuboi R, Ueki R, Ogawa H. Immunohistochemical localization of basic fibroblast growth factor in skin diseases. Acta Derm Venereol 1993; 73: 81-83.
12. Detmar M, Velasco P, Richard L, et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Am J Pathol 2000; 156: 159-167.
13. Horio T. Indications and action mechanisms of phototherapy. J Dermatol Sci 2000; 23 (Suppl 1): S17-S21.
14. Honigsmann H. Phototherapy for psoriasis. Clin Exp Dermatol 2001; 26: 343-350.
15. Gasparro FP. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence. Am J Clin Dermatol. 2000; 1: 337-348.
16. Bethea D, Fullmer B, Syed S, et al. Psoralen photobiology and photochemotherapy: 50 years of science and medicine. J Dermatol Sci 1999; 19: 78-88.
17. Mildner M, Weninger W, Trautinger F, Ban J, Tschachler E. UVA and UVB radiation differentially regulate vascular endothelial growth factor expression in keratinocyte-derived cell lines and in human keratinocytes. Photochem Photobiol 1999; 70: 674-679.
18. Longuet-Perret I, Schmitt D, Viac J. Tumour necrosis factor-alpha is involved in the contrasting effects of ultraviolet B and ultraviolet A1 radiation on the release by normal human keratinocytes of vascular permeability factor. Br J Dermatol 1998; 138: 221-224.
19. Kuroda K, Sapadin A, Shoji T, Fleischmajer R, Lebwohl M. Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. J Invest Dermatol 2001; 116: 713-720.
20. Braveman IM, Sibley BA. Role of the microcirculation in the treatment and pathogenesis of psoriasis. J Invest Dermatol 1982; 78: 12-17.
21. Okamoto H, Horio T. The effect of 8-methoxypsoralen and long-wave ultraviolet light on Langerhans cell. J Invest Dermatol 1981; 77: 345-346.
22. Bensch KG, Davison PM, Karasek MA. Factors controlling the in Vitro growth pattern of human microvascular endothelial cells. J Ultrastruct Res 1983; 82: 76-89.
23. Yeh CH, Peng HC, Yang RS, Huang TF. Rhodostomin a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v) beta(3) blockade of endothelial cells. Mol Pharmacol 2001; 59: 1333-1342.
24. Detmar M., Orfanos CE. Tumor necrosis factor-alpha inhibits cell proliferation and induces class II antigens and cell adhesion molecules in cultured normal human keratinocytes in vitro. Arch Dermatol Res 1990; 282: 238-245.
25. Cai G, Lian J, Shapiro SS, Beacham DA. Evaluation of endothelial cell migration with a novel in vitro assay system. Methods Cell Sci 2000; 22: 107-114.
26. Legitimo A, Consolini R, Di Stefano R, Bencivelli W, Mosca F. Psoralen and UVA light: an in vitro investigation of multiple immunological mechanisms underlying the immunosuppression induction in allograft rejection. Blood Cells Mol Dis 2002; 29: 24-34.
27. Walter JF, Voorhees JJ, Kelsey WH, Duell EA, Arbor A. Psoralen plus black light inhibits epidermal DNA synthesis. Arch Dermatol 1973; 107: 861-865.
28. Duthie MS, Kimber I, Norval M. The effects of ultraviolet radiation on the human immune system. Br J Dermatol 1999; 140: 995-1009.
29. Lugar TA. Immunomodulation by UV light: role of neuropeptides. Eur J Dermatol 1998; 8: 198-199.
30. Morison WL, Parrish JA, Block KJ, Krugler JI. In vivo effect of PUVA on lymphocyte function. Br J Dermatol 1981; 104: 405-413.
31. Okamoto H, Horio T, Maeda M. Alteration of lymphocyte functions by 8-methoxypsoralen and long wave ultraviolet light radiation. II. The effect of in vitro PUVA on IL-2 production. J Invest Dermatol 1987; 89: 24-26.
32. Miyauchi-Hashimoto H, Okamoto H, Tanaka K, Horio T. Ultraviolet radiation-induced suppression of natural killer cell activity is enhanced in xeroderma pigmentosum group A(XPA) model mice. J Invest Dermatol 1999; 112: 965-970.
33. Bhushan M, Young HS, Brenchley PE, Griffiths CE. Recent advances in cutaneous angiogenesis. Br J Dermatol 2002; 147: 418-425.
34. Velasco P, Lange-Asschenfeldt B. Dermatological aspects of angiogenesis. Br J Dermatol 2002; 147: 841-852.
35. British Photodermatology Group guidelines for PUVA .. Br J Dermatol. 1994; 130: 246-255.
36. Huuskonen H, Koulu L, Wilen G. Quantitative determination of methoxsalen in human serum, suction blister fluid and epidermis by gas chromatography mass spectrometry. Photodermatology 1984; 1: 137-140.
37. de Wolff FA, Thomas TV. Clinical pharmacokinetics of methoxsalen and other psoralens. Clin Pharmacokinet 1986; 11: 62-75.
38. Tanew A, Ortel B, Rappersberger K, Honigsmann H. 5-Methoxypsoralen (Bergapten) for photochemotherapy. Bioavailability, phototoxicity, and clinical efficacy in psoriasis of a new drug preparation. J Am Acad Permatol 1988; 18: 333-338.
39. Gasparro FP. Psoralen photobiology: recent advances. Photochem Photobiol 1996; 63: 553-557.
40. Luftl M, Rocken M, Plewig G, Degitz K. PUVA inhibits DNA replication, but not gene transcription at nonlethal dosages. J Invest Dermatol 1998; 111: 399-405.
41. He YY, Huang JL, Ramirez DC, Chignell CF. Role of reduced glutathione efflux in apoptosis of immortalized human keratinocytes induced by UVA. J Biol Chem 2003; 278: 8058-8064.
42. Coven TR, Walters IB, Cardinale I, Krueger JG. PUVA-induced lymphocyte apoptosis: mechanism of action in psoriasis. Photodermatol Photoimmunol Photomed 1999; 15: 22-27.